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Antibodies of various specificities
may be found in patients receiving
multiple blood transfusions. Investigations in the past decade have established that some of these patients
may develop antibodies specifically
directed against leukocyte antigens
and not against those of the red cells
(Bridges, Boyd , and Nelson , 1962;
Dausset, 1954; Felbo and Jensen,
1962; Killman, 1958; Payne, 1947 ;
van Loghem et al, 1958; van Rood ,
Leeuwen, and Eernisse, 1959 ; van
Leeuwen , 1963). The transfusion of
patients whose sera contain these
antibodies, known as leukoagglutinins, frequent ly results in febrile
transfusion reactions. In the past,
most febri le transfusion reactions
were attributed to the presence of
pyrogens in the blood-collecting apparatus. However, with the use of
disposable equipment, this source of
reactions has been virtuall y eliminated, and most authors agree that
leukocyte-leukoagglutinin
incompatibility is a major cause of such
febri le reactions today (Bridges,
Boyd, and Nelson, 1962; Brittingham, and Chaplin, 1957; Dausset,
1954; Hossaini ; Killman, 1958;
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Payne, 1957 ; van Loghem et al,
1958 ; Wilson, Rheins, Naegeli , and
George, J959). This study was undertaken to determine in vivo and
in vitro the specificity of leukoagglutinins, and to establish the nature of the pyrogenic reaction .
Materials and Methods
Normal sera were obtained from
donors in the blood bank of the
Ohio State University Hospital. All
pathologic sera were obtained from
patients on the hematology service
of the department of medicine.

Leukocyte Suspensions
Blood was collected from normal
donors in the blood bank in 15 ml
amounts in si liconized tubes containing 0.3 ml of 5% disodium versenate (EDTA). After thorough
mixing of blood and anticoagulant,
2 ml of 6 % dextran were added,
and the contents of the tube were
mixed again by inversion. The
blood was divided equally and
pipetted into three 22 x 1.5 cm test
tubes. After 90 minutes of sedimentation, the supernatant plasma, rich
in leukocytes and platelets, was
transferred to a 15 ml graduated
centrifuge tube. The tube was spun
in a centrifuge at 800 rpm for 15
minutes. The supernatant fluid was
removed and, by the same centrifugation techniq ue, the cells in the

sediment were washed twice with
saline-serum-anticoagulant
(SSA)
solution. The latter solution was
prepared by mixing 2 ml of in activated normal blood group AB
serum with 0.5 ml of 5% EDTA ,
and then diluting it to 200 ml with
physiological saline. After the second washing, the supernatant was
removed as completely as possible,
and the button of cells was homogeneously suspended in a fresh 0.5 ml
aliquot of SSA solution. A white cell
count was made, and addition al
SSA was added to produce a cel l
density of 8 to 10,000 per mm".

Red Cells
The red cell portion remammg
after sedimentation was washed in
saline and was used for the absorption of erythrocyte isoagglutinins.
All erythrocyte isoagglutinins were
removed from test sera by absorption with washed red cells of the
leukocyte donor before Jeukoagglutination tests were performed .

Leukoagglutination Test
The leukoagglutination tests were
performed by placing 0.2 ml of a
1: 8 dilution of the absorbed sera in
physiological saline in 10 x 75 ml
tubes, followed by one drop of
bromelin solution (Dade Reagents,
Inc. , Miami, Florida) or 0.1 ml of
the SSA suspended leukocytes. The
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tubes were shaken, left to stand for
15 minutes at room temperature,
and then were spun for 30 seconds
in a serofuge (Clay-Adams). After
tapping the tubes gently to disperse
the cells in the sediment, the solutions were examined for agglutination by holding the tubes in the
direct beam of a light source over a
concave magnifying mirror.
A known positive control and a
negative control were included in
each series of tests. Each serum
was tested against two cell suspensions prepared from randomly selected donors.

Induction of Febrile Transfusion
Reaction
The following sera were used:
1. Serum from a Group A, Rho
(D) positive blood patient with
aplastic anemia, whose serum had
shown strong Jeukoagglutinating activity.
2. Serum from an apparently
normal individual (negative control)
of the same blood group and Rho
(D) as that of the patient.
Five ml of both the control and
the leukoagglutinin-positive sera
were diluted to 30 ml using injectable physiological saline followed
by Seitz-filtration.
Basal white cell and differential,
red cell, reticulocyte, and platelet
counts were obtained by finger stick;
temperature, pulse rate, and blood
pressure were recorded on a male
volunteer (AAH). Two hours after
obtaining the basal data, a slow
intravenous transfusion of 250 ml
of physiological saline was begun.
Twenty-five minutes later the control Seitz-filtered serum was injected into the saline bottle and infusion continued. At half-hourly
intervals for six hours, counts were

i
16

taken, and temperature, pulse, and
pressure were recorded.
Under similar environmental,
temporal and nutritional conditions,
the same volunteer was injected one
week later with an equal amount of
the identically processed positive
serum, and similar observations
were recorded as above.
Results

In all, 395 sera obtained from
375 normal individuals and patients
with various pathological conditions
were tested for leukoagglutinins.
When a patient gave a negative test
and subsequently became positive,
the reactions were recorded as two
specimens; this accounts for the
difference in numbers. There were
20 such cases. Many of the pathological groups had received multiple transfusions. Results of the sera
tested for Jeukoagglutinins and the
number of transfusions received by
each patient prior to the first testing
of the serum are shown in Table 1.
Table 2 lists the diagnoses of patients whose sera were tested for
leukoagglutinins before they received any blood transfusions. None
of the seven Jeukoagglutinin-positive sera was from a woman who
had ever been pregnant.
Cytologic studies of agglutinated
cells revealed participation of both
the granulocytes and mononuclear
cells in the clumps. Clumping resulted in complete loss of the ameboid movement of cells in the positive tubes, whereas cells in the
negative sera remained mobile,
though sluggish.
Transfused patients were classified by clinical diagnosis. Those
showing transfusion reactions, Jeukoagglutinins, or both, are presented in Table 3.
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TABLE 1

TABLE 2

Distribution of 395 Sera Tested for L.A.*

Diseases Found in Patients Showing Negative and Positive Leukoagglutinis Prior to Receiving any
Transfusion

Number
tested

No L.A.

L.A.
demonstrated

From patients never transfused prior to
testing
From patients receiving less than 8 units
From patients receiving more than 8 but
less than 20 units
From patients receiving more than 20
but less than 50 units
From patients receiving more than 50
units

247

240t

7

63
59

48
42

15
17

16

9

7

10

3

7

Total

395

Number of blood units

Disease

342

53

* L.A.: Leukoagglutinins
t Some of these patients were subsequently transfused and re-tested.

TABLE 3

Correlation between Disease, Transfusion Reaction and L.A. Production
Number Showing
Disease Group

Reac- Reacti on tion and
only
L.A.

L.A.
only

- -Acute leukemias
Chronic leukemias
Lymphomas
Hemolytic anemias
Refractory anemias
Thrombocytopenic purpuras
Coagulation defects
Non-hematologic diseases* .
Insufficient data
Total

Both
Total
negative

NumNumber
b er
.
tested positive

Rheumatoid arthritis
Chronic pyelonephritis
Acute monoblastic
leukemia
Healthy
Miscellaneous*

133

1
0

Total

240

7

9

4

4
18
76

* Diseases included:
1. Other acute leukemias
2. Chronic leukemias
3. Lymphomas
4. Hemolytic anemias
5. Refractory anemias
6. Lupus erythematosus disseminatus
7. Coagulation defects
8. Various forms of nonhematologic diseases

- - - - --

3
4
4
4
4
0
1
2

7
10
4
2
4
2
0
5

6
4
1
0
0
0
0
1

22
19
15
6
7
0
4
5

38
37
24
12
15
2
5
13
2

22

34

12

78

148

* Six untransfused patients showed leukoagglutinins (L.A .) . (See Table 1)
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Fig. 1.

Figure 1 shows white cell, red
cell, platelet, and reticulocyte
counts, temperature, and symptoms
experienced during the infusion of
both the control and positive sera.
No change occurred in these parameters following the infusion of
the control serum. On the contrary,
the following alterations occurred
after the infusion of the positive
serum. One hour after the start of
the infusion of serum, there was a
marked leukopenia, lasting for 90
minutes, followed by a gradual return to the basal level, and a subsequent leukocytosis over the next
three hours. Only slight changes in
the reticulocyte and red cell counts
occurred, but a significant thrombocytopenia was observed. P latelet
18

levels remained at the basal value
for two hours, but 30 minutes later
the count showed a precipitous
drop. The thrombocytopenia persisted for two hours, and then the
count returned to normal levels. No
further counts were made.
Fifteen minutes before the completion of the infusion (40 minutes
after starting the serum infusion),
the subject developed a frontal
headache, which increased in intensity over a period of an hour.
Within 15 minutes after the onset
of the headache, a shaking chill, a
mild tachypnea (28 breaths per
minute), and a 2-3° rise in temperature (which reached its peak
within three hours) developed.
Table 4 shows the basal red cell,
reticulocyte, platelet, white cell, and
differential counts and the values
obtained over the six hour study
period following the injection of the
positive serum. Since detailed listing of the hourly values following
the injection of the control serum
did not contribute additional information, only the recorded range of
values were included in this table.
The values obtained with regard to
the red cell, reticulocyte, platelet,
and total white cell counts have
been mentioned already in Figure 1.
Differential counts obtained after
the infusion of the control serum
varied slightly from basal values.
However, there were marked absolute neutrophenia, eosinopenia, lymphopenia and monocytopenia. The
neutrophenia continued for over
three hours and was followed by
a neutrophilic leukocytosis. Values for the remaining white cell
elements remained below normal
levels over the six-hour period.
However, the monocytes showed
signs of reappearance five hours
after infusion.
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TABLE 4

Changes Induced in a Human Volunteer by Injection of Leukoagglutinin
Positive Control Sera
I.

Control
Serum
Cells

Test Serum

Range of
values
over 6
hours

Time in hours after injection

-

RBC 's in millions
Reticulocytes 3

5.2- 5.3

2

0

1

-

--

5.8

5.5

---

-

1.6

0.2

1.2-2.0

3

- -

6.1

5.5
- -

4

-

6

5

-- --

5.1

- -

--

5.1

5.2

- -- -- -- -

0 .8

0.4

1.4

0.4

0.6

- -- -- ---- - - -

Platelets in 1000 's

190-208

214

204

184

36

74

------- WBC

Total

4150-5000 5000

Total
3

1287
66

1656

---

-

3050-3071 3300
61-74
66

- -

Eos.

Total
%

0-250
0-5

Baso.

Total
%

0-0
0-0

4500

- -- - - -

- Polys.

2300

1950

0
0

0
0

-

-

Lympho. Total
3

747-900
18- 27

1300
26

Mono.

125-150
2- 3

400
8

Total
3

0
0
-

Discussion

This study confirms the work of
other investigators (Bridges, Boyd,
and Nelson, 1962; Dausset, 1954;
Felbo and Jensen, 1962; Killman,
1958; van Rood, Leeuwen, and
Eernisse, 1959; van Rood and von
Leeuwen, 1963; Wilson, Rheins,
Naegeli, and George, 1959) that the
mechanism of the leukoagglutina-

8650

12950

8391
97

12600
95

552
24
92
4

0
0

0
0

0
0

- -- -- -

-

0
0
--

~~

360
8

- -- -- 117
6

6175
95

0
0

0
0

--

-

546
28

----

6500

- -- -- -- -

0
0

------0
0

-

- -- - - -

4095
91

72

194

45
1

0
0

0
0

325
5

173
2

----- -

0
0
-

88
3

- -- 0
0

86
1

259
2

tion phenomenon is immunologic
and is specific for leukocytes. There
is a significantly higher frequency
of occurrence of leukoagglutinins in
patients receiving multiple transfusions as compared to patients who
were not transfused. Table 1 shows
that only seven out of 247 sera from
the latter group gave a positive test.
In contrast, 46 out of 148 sera from
transfused patients were positive.

Twelve of the leukoagglutininpositive patients had been tested
before any transfusion. All their
sera were negative then, but became
positive after one or more blood
transfusions. Yet other patients,
who had been tested at different
stages of transfusion therapy, were
found to become leukoagglutininpositive as the number of transfusions was increased. Table 1 shows
the direct relationship between the
number of leukoagglutinin-positive
patients and the number of units of
blood they had received. Among the
46 leukocyte agglutinating sera
from transfused patients, only three
were known to possess a concomitant red cell antibody. Therefore,
the increase in the number of leukoagglutinin-positive patients with increasing transfusions may have been
caused by further stimulation by the
antigen or antigens of transfused
leukocytes.
Absence of reaction following the
injection of the control serum indicates that all pyrogenic agents had
been eliminated from the serum.
Variations in differentials, in blood
counts and temperatures, in pulses
and pressures during the negative
control experiment were within the
range of physiological variations
and experimental error.
Excluding the unlikely possibility
of sensitization by the negative control serum, it may be assumed that
the reaction to the positive serum
was due to the specific effect of the
injected leukoagglutinins on circulating leukocytes. The possibility of
a pyrogenic reaction must be considered, however, as marked leukopenia is not characteristic of this
type of transfusion reaction.
The marked leukopenia in the
absence of a change in the red cell
19
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count indicates that the reaction was
not caused by erythrocyte antibodies. The simultaneous onset of
neutropenia, eosinopenia, lymphopenia and monocytopenia is additional evidence suggesting that the
antibody is directed against granular
and mononuclear leukocytes. This
reinforces the findings by microscopic studies that both cell types
participate in the clumps of cells
seen in positive leukoagglutinin
tests. The thrombocytopenia was
shown to be associated with the
presence of platelet antibodies in
the injected serum.
The injection of a serum known
to contain leukoagglutinins into a
normal individual resulted in the
development of a febrile reaction
and a mild leukopenia. In an earlier
report, one of us (AAH) explained
this on the basis of passive transfer
of leukoagglutinins.
Using the continuous-flow electrophoresis cell, Wilson, Rheins,
and Naegeli (1959) fractionated
seven negative sera and ten sera
from six leukoagglutinin-positive
patients. Results showed a rise in
activity of the y-globulin fraction
only in the positive sera. Persistence
of leukoagglutinins in positive sera
after absorption indicates that the
red cells lacked the corresponding
antigens.
There was an absence of a
marked reduction in the severity of
febrile transfusion reactions when
packed red cells with a leukocyte
count of less than 1000 per mm3
were given to three leukoagglutininpositive patients who had experienced multiple febrile transfusion
reactions. The mild reactions after
receiving the processed blood might
have been due to the almost inevitable contamination of packed,
washed, red cell preparations by a
few unremoved leukocytes.
Summary

Results of testing sera from normal individuals and pathological patients, using a bromelin technique
for the detection of leukoagglutinins, are reported. These results,
20

supported further by an in vivo
experiment, suggested that the phenomenon of leukoagglutination is
immunologic in nature and that leukoagglutinins may be the cause of
some febrile transfusion reactions.
These are specifically directed
against leukocytes, and do not involve the red cell series. Furthermore, the antigen (or antigens) is
probably present in both the granulocytes and the mononuclear leukocytes. Anti-platelet antibodies could
be presumed to be the cause of
thrombocytopenia.
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